| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $2.63 (Beat by $0.29) |
| EPS GAAP Actual | $2.63 (Beat by $0.29) |
| Revenue Actual | $64.009B |
| Revenue Surprise | Beat by $64009M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.43221 |
| EPS GAAP Estimate | $2.43221 |
| Revenue Estimate | $65.391453418B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2030 | 15.05 | 15.04 | 14.41698 | 15.3119 | 1 |
| Jun 2029 | 10.67 | 21.21 | 10.43495 | 11.03818 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.89 | -0.14687 | 64.009B | 18.33% | -339.44M |
| FQ2 2025 (Jun 2025) | 1 | 1 | 60.159B | 0.49% | 60159M |
| FQ1 2025 (Mar 2025) | 2.11 | 2.11 | 54.878B | -0.06% | 54878M |
| FQ4 2024 (Dec 2024) | 1.65 | 1.65 | 55.264B | -3.95% | 55264M |
| FQ3 2024 (Sep 2024) | 1.71 | 1.71 | 52.277B | -4.76% | 52277M |
| FQ2 2024 (Jun 2024) | 0.96 | 0.96 | 59.867B | 10.71% | 59867M |
| FQ1 2024 (Mar 2024) | 1.06 | 1.06 | 54.911B | 8.06% | 54911M |
| FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 57.445B | 10.4% | 57445M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.43221
Consensus Revenue Estimates
65.391453418B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 3.18505 | -- | 3.00427 | 3.2784 | 4 |
| FQ4 2027 (Dec 2027) | 2.64347 | -- | 2.49343 | 2.72095 | 5 |
| FQ3 2027 (Jul 2027) | 2.45968 | -- | 2.37418 | 2.59322 | 1 |
| FQ1 2027 (Mar 2027) | 2.74332 | -- | 2.68862 | 2.78682 | 4 |
| FQ4 2026 (Oct 2026) | 2.03709 | -- | 1.96628 | 2.14769 | 1 |
| FQ3 2026 (Jul 2026) | 2.18227 | 13.39 | 2.04839 | 2.31117 | 4 |
| FQ1 2026 (Mar 2026) | 2.43221 | 13.25 | 2.39476 | 2.47013 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 74.18B | -- | 70.95B | 75.86B | 3 |
| FQ4 2027 (Dec 2027) | 71.4B | -- | 68.28B | 73.01B | 6 |
| FQ3 2027 (Jul 2027) | 73.18B | -- | 71.22B | 76.23B | 3 |
| FQ1 2027 (Mar 2027) | 62.96B | -- | 62B | 63.73B | 4 |
| FQ4 2026 (Oct 2026) | 62.12B | -- | 60.46B | 64.72B | 4 |
| FQ3 2026 (Jul 2026) | 61.87B | -3.46 | 58.95B | 64.68B | 2 |
| FQ1 2026 (Mar 2026) | 65.39B | 16.08 | 64.62B | 66.18B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.03687 | 1.89 | -0.14687 | -7.77% |
| FQ2 2025 (Jun 2025) | 1 | 1 | 100% | |
| FQ1 2025 (Mar 2025) | 2.11 | 2.11 | 100% | |
| FQ4 2024 (Dec 2024) | 1.65 | 1.65 | 100% | |
| FQ3 2024 (Sep 2024) | 1.71 | 1.71 | 100% | |
| FQ2 2024 (Jun 2024) | 0.96 | 0.96 | 100% | |
| FQ1 2024 (Mar 2024) | 1.06 | 1.06 | 100% | |
| FQ4 2023 (Dec 2023) | 1.44 | 1.44 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $64.35B | $64.01B | $-339.44M | -0.53% |
| FQ2 2025 (Jun 2025) | $0B | $60.16B | $60159M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $54.88B | $54878M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $55.26B | $55264M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $52.28B | $52277M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $59.87B | $59867M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $54.91B | $54911M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $57.45B | $57445M | 100% |